Cardiovascular Microcatheter Market Report 2026

The cardiovascular microcatheter market size has grown strongly in recent years. It will grow from $1.08 billion in 2025 to $1.17 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, expansion of minimally invasive interventional procedures, improvements in catheter material engineering, growing adoption of catheter-based diagnostics, expansion of cardiac catheterization laboratories.

The cardiovascular microcatheter market size is expected to see strong growth in the next few years. It will grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing demand for complex endovascular interventions, rising aging population with vascular disorders, growth in neurovascular procedure volumes, increasing innovation in microcatheter design, expanding adoption of minimally invasive cardiology treatments. Major trends in the forecast period include increasing adoption of steerable and braided microcatheters, rising demand for neurovascular and complex coronary procedures, growing use of balloon-assisted and infusion microcatheters, expansion of guidewire-compatible precision devices, enhanced focus on trackability and torque control.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the cardiovascular microcatheter market in the coming years. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension. The prevalence of cardiovascular diseases is rising primarily due to increasingly sedentary lifestyles associated with urbanization, contributing to obesity, hypertension, and metabolic disorders. A cardiovascular microcatheter helps treat cardiovascular diseases by enabling precise navigation through tiny, complex vessels to deliver guidewires, contrast, or therapeutic devices directly to the target lesion with minimal trauma. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular disease is driving the growth of the cardiovascular microcatheter market.

Companies operating in the cardiovascular microcatheter market are adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For example, in February 2024, BIOTRONIK, a Germany-based medical technology company, introduced the Micro Rx catheter, a rapid exchange microcatheter designed to enhance guidewire support during percutaneous coronary interventions (PCI). Exclusively distributed by BIOTRONIK and manufactured by Interventional Medical Device Solutions (IMDS), the device expands BIOTRONIK’s U.S. portfolio of IMDS-developed products, which also includes the NHancer Rx, TrapIT, and ReCross catheters. The Micro Rx catheter incorporates a reinforced distal shaft with a core wire positioned between dual braided layers to optimize pushability and support, along with a tapered tip featuring an ultra-small leading edge to facilitate high penetration capability. It also includes a proximal-end-stop design that enables smooth integration with guide extension catheters to provide additional procedural support.

In January 2025, Argon Medical Devices Inc., a US-based provider of medical device solutions, acquired SeQure and DraKon microcatheters from Guerbet SA for an undisclosed amount. Through this acquisition, Argon Medical aims to broaden its therapeutic device offerings and enhance its portfolio of interventional oncology and vascular access products by incorporating established microcatheter technologies. Guerbet SA is a France-based pharmaceutical and medical imaging company that develops and markets contrast agents, imaging solutions, delivery systems, and related medical devices for diagnostic and interventional imaging.

Major companies operating in the cardiovascular microcatheter market are Medtronic Plc, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc., Lepu Medical Technology Co. Ltd., Asahi Intecc Co. Ltd., Baylis Medical Company Inc., ACIST Medical Systems Inc., Acandis GmbH, BrosMed Medical Co. Ltd., Relisys Medical Devices Limited, Sahajanand Medical Technologies Ltd. (SMT), Reflow Medical Inc., Acrostak AG, and ShanghAI Kindly Medical Instruments Co. Ltd.

Tariffs are impacting the cardiovascular microcatheter market by increasing costs of imported specialty polymers, braided metals, precision extrusion equipment, and micro-manufacturing components used in diagnostic and therapeutic catheter production. North America and Europe are most affected due to reliance on cross-border sourcing of high-precision materials, while Asia-Pacific faces cost pressure on export-oriented catheter manufacturing. These tariffs are increasing production costs and affecting pricing strategies for hospitals and catheterization labs. However, they are also encouraging localized manufacturing, supplier diversification, and investments in advanced domestic catheter fabrication capabilities.

The cardiovascular microcatheter market research report is one of a series of new reports that provides cardiovascular microcatheter market statistics, including cardiovascular microcatheter industry global market size, regional shares, competitors with a cardiovascular microcatheter market share, detailed cardiovascular microcatheter market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular microcatheter industry. This cardiovascular microcatheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A cardiovascular microcatheter is a slender, extremely flexible, and precisely engineered catheter created to safely traverse narrow, winding, and sensitive blood vessels within the cardiovascular system while delivering high levels of control, stability, and responsiveness during intravascular interventions. It is manufactured using advanced biocompatible materials and specialized design elements that provide excellent trackability, effective torque transfer, and mechanical durability, enabling precise placement and dependable performance in complex vascular anatomies.

The primary product types of cardiovascular microcatheters include guiding catheters, diagnostic catheters, therapeutic catheters, balloon catheters, and ablation catheters. Guiding catheters are designed to provide stability and enable the delivery of interventional devices to specific cardiovascular targets. These devices are manufactured using materials such as polyurethane, polyvinyl chloride, silicone, and other specialized polymers. The applications include coronary intervention, peripheral intervention, neurovascular intervention, and pediatric cardiology procedures, and the end users comprise hospitals, cardiac catheterization laboratories, ambulatory surgical centers, research institutions, and academic organizations.

The cardiovascular microcatheter market consists of sales of diagnostic microcatheters, therapeutic microcatheters, guidewire-compatible microcatheters, balloon-assisted microcatheters, infusion microcatheters, aspiration microcatheters, steerable microcatheters, and braided microcatheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.